Author | Luis A. Diaz, MD | OncLive

Author | Luis A. Diaz, MD

Articles

Dr. Diaz on Response Rates for MSI-H and NTRK Fusions in GI Cancer

December 13, 2017

Video

Luis A. Diaz, MD, head of the division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center, discusses the responses seen with microsatellite-instability high (MSI-H) and NTRK fusions in patients with gastrointestinal cancer.

Dr. Diaz on Response Rates With Pembrolizumab for CRC

August 03, 2017

Video

Luis A. Diaz, MD, head of the division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center, discusses the response rates of pembrolizumab (Keytruda) for patients with colorectal cancer (CRC).

Dr. Diaz on Pembrolizumab for CRC

June 20, 2017

Video

Luis A. Diaz, MD, head of the division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center, discusses the impact of pembrolizumab (Keytruda) in patients with colorectal cancer (CRC).

x